MedPath

General Injectables & Vaccines, Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

37

FDA:37

Drug Approvals

Sensorcaine

Approval Date
Dec 29, 2022
FDA

PROMETHAZINE HYDROCHLORIDE

Approval Date
Dec 29, 2022
FDA

Promethazine Hydrochloride

Approval Date
Dec 29, 2022
FDA

Promethazine Hydrochloride

Approval Date
Dec 29, 2022
FDA

NAROPIN

Approval Date
Dec 29, 2022
FDA

Sensorcaine

Approval Date
Dec 29, 2022
FDA

MIDAZOLAM

Approval Date
Dec 28, 2022
FDA

Midazolam

Approval Date
Dec 28, 2022
FDA

Tigan

Approval Date
Dec 27, 2022
FDA

Suprane

Approval Date
Dec 27, 2022
FDA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.